Immunovia AB (publ)
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Immunovia AB (publ)'s past years’ income statements indicate that its last revenue has increased compared to the previous period by 38% to $1,575,000. Profit margin reached -19647%. Total operating expenses were $291,353,000.

Profit Margin

Immunovia AB (publ) (LSE:0G8X.L): Profit margin
2014 359.16K -8.85M -2466.58%
2015 205.19K -7.38M -3598.41%
2016 177.28K -14.72M -8304.88%
2017 148.96K -45.23M -30364.72%
2018 332.59K -86.53M -26019.22%
2019 356K -114.52M -32168.82%
2020 362K -147.45M -40732.32%
2021 844K -157.39M -18649.05%
2022 1.14M -145.03M -12666.72%
2023 1.57M -309.43M -19646.92%

0G8X.L Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
1.57M1.14M844K362K356K332.59K148.96K177.28K205.19K359.16K
Cost of revenue
6.68M4.21M-14.96M-40.02M-26.71M-25.05M-24.04M-24.29M-16.79M7.28M
Gross profit
-5.10M-3.06M15.81M40.38M27.07M25.38M24.18M24.46M16.99M-6.92M
Operating exp.
Research and development
34.41M47.90M43M48.1M34.2M024.04M016.79M0
Selling and marketing
0000000000
Total operating expenses
291.35M188.14M182.55M175.06M141.42M113.83M69.76M39.48M24.43M9.31M
Operating income
-296.46M-191.15M-166.74M-134.67M-114.35M-87.70M-45.51M-14.97M-7.42M-8.95M
Other income (expenses), net
-12.97M23.05M10.77M-11.69M-167K1.17M287.56K254.78K40.45K100.41K
Income before tax
-309.43M-168.09M-155.96M-146.03M-114.51M-86.53M-45.23M-14.72M-7.38M-8.85M
Income tax expense
0-23.05M1.43M1.41M4K7.34K297.73K255.93K41.27K100.89K
Net income
-309.43M-145.03M-157.39M-147.45M-114.52M-86.53M-45.23M-14.72M-7.38M-8.85M
Earnings per share
Basic EPS
-3.95-5.95-6.45-6.41-5.43-4.33-2.48-0.91-0.6-0.74
Diluted EPS
-3.95-5.95-6.45-6.41-5.43-4.33-2.48-0.91-0.6-0.71